HuMax-IL8

anti-IL-8 monoclonal antibody · Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HuMax-IL8, covering 2017-02-03 to 2017-02-03. Get the full timeline:

Most recent: Clinical Trial Update: HuMax-IL8 (Interleukin8) in Patients With Advanced Malignant Solid Tumors [Phase 1]